Lupin schizophrenia drug Aripiprazole gets USFDA okay Ruchika Sharma20 March 2024 1:30 PM ISTAripiprazole Tablets USP are indicated for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I...
Olanzapine and samidorphan combination effective for long-term treatment of schizophrenia, bipolar disorder Medha Baranwal12 Jan 2024 5:00 AM ISTUSA: A phase 3, open-label extension study has shed light on the long-term safety, durability, and tolerability of olanzapine and samidorphan...
Among bipolar I depression patients adjunctive antidepressant treatment beyond 8 weeks offers no significant benefit: NEJM Dr. Kamal Kant Kohli21 Nov 2023 4:45 PM ISTUSA: A recent study of patients with bipolar I disorder and a recently remitted depressive episode revealed that adjunctive treatment with...
Olanzapine and samidorphan combo mitigates antipsychotic-associated weight gain in psychiatric illness Dr. Kamal Kant Kohli7 Sept 2023 9:45 AM ISTUSA: A combination of olanzapine and samidorphan (OLZ/SAM) led to less weight gain at week 12 versus olanzapine while providing similar antipsychotic...
Iloperidone Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study Dr. Kamal Kant Kohli23 Dec 2022 10:30 AM ISTAccording to results from a phase 3 study, Iloperidone was linked to significant improvement in adults with bipolar I disorder.In clinical study...
Zydus Lifesciences US arm bags USFDA nod for schizophrenia drug Cariprazine Ruchika Sharma13 Sept 2022 11:01 AM ISTCariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with...
